ARCHIVES

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

This article is from The Cancer Letter archive.

Vol. 20 No. 19 | May 13, 1994

Download PDF Visit The Full Archive

Related Articles

How Much Is Life Worth? The $440 Billion Question

July 31, 2009

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011

NIH Updates Policy On Large Grants

May 10, 1996

Ovariectomy Without HRT Increases Death Rate

September 29, 2006

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005